BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/3/2024 11:10:16 AM | Browse: 22 | Download: 0
Category |
Oncology |
Manuscript Type |
Case Report |
Article Title |
Pneumocystis pneumonia in stage IIIA lung adenocarcinoma with immune-related acute kidney injury and thoracic radiotherapy: A case report
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Ya-Wen Zheng, Jia-Chao Pan, Jin-Feng Wang and Jian Zhang |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Shandong Natural Science Foundation |
ZR2021QH034 |
China Postdoctoral Science Foundation |
2023M731305 |
|
Corresponding Author |
Ya-Wen Zheng, MD, PhD, Associate Chief Physician, Department of Oncology, Central Hospital Affiliated to Shandong First Medical University, No. 105 Jiefang Road, Jinan 250000, Shandong Province, China. zyawen06@126.com |
Key Words |
Pneumocystis pneumonia; Immune related adverse events; Immunotherapy; Thoracic radiotherapy; Acute kidney injury; Case report |
Core Tip |
A patient with squamous lung cancer was treated with triplimab combined with paclitaxel, carboplatin, and radical thoracic radiation therapy. Despite the good therapeutic effect, he developed a grade 3 immune-related acute kidney injury, prompting high-dose corticosteroids treatment. Eight weeks later, the patient developed severe pneumonia with spontaneous pneumothorax, and was diagnosed with Pneumocystis jirovecii pneumonia (PJP) co-infection with the herpes simplex virus 1 and cytomegalovirus. PJP is rare but might occur in patients with immune checkpoint inhibitor adverse events, highlighting the need to be differentiated from tumor progression or immune-related adverse events. |
Citation |
Zheng YW, Pan JC, Wang JF, Zhang J. Pneumocystis pneumonia in stage IIIA lung adenocarcinoma with immune-related acute kidney injury and thoracic radiotherapy: A case report. World J Radiol 2024; In press |
|
Received |
|
2024-07-11 14:16 |
|
Peer-Review Started |
|
2024-07-11 14:16 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-08-05 05:50 |
|
Revised |
|
2024-08-16 15:33 |
|
Second Decision |
|
2024-09-03 02:45 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-09-03 11:10 |
|
Articles in Press |
|
2024-09-03 11:10 |
|
Publication Fee Transferred |
|
2024-09-04 00:42 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
|
ISSN |
1949-8470 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345